ArticleExperimental & molecular medicine2025
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron.
Yingwei Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it